Crispr Therapeutics (CRSP) is up 16.4%, or $9.06 to $64.15.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CRSP:
- Crispr Therapeutics rises 11.9%
- Crispr Therapeutics AG Stock Soars Amid Strategic Moves
- Cathie Wood Makes $5M Biotech Buy, Trims Stake in Roku
- Cathie Wood’s ARK Investment buys 103K shares of Crispr Therapeutics today
- Crispr Therapeutics AG: Strategic Positioning and Growth Potential in Gene Editing